TCL Archive IDMC Recommends Halting Phase III Trial Of Onartuzumab in MET-Positive NSCLC March 28, 2014
TCL Archive In Brief: Pollock Named Director of Surgical Oncology At Ohio State Comprehensive Cancer Center May 8, 2013
TCL Archive In Brief: NCAB to Hear Report On Treatment Programs, Discuss Hogness Plan For New Type of Review November 3, 1978